关注
Tae Hwan Kim
Tae Hwan Kim
College of Pharmacy, Daegu Catholic University
在 cu.ac.kr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs
S Shin, TH Kim, SW Jeong, SE Chung, DY Lee, DH Kim, BS Shin
Plos one 14 (5), e0216875, 2019
862019
Quantitative analysis of lab-to-lab variability in Caco-2 permeability assays
JB Lee, A Zgair, DA Taha, X Zang, L Kagan, TH Kim, MG Kim, H Yun, ...
European Journal of Pharmaceutics and Biopharmaceutics 114, 38-42, 2017
842017
First penicillin-binding protein occupancy patterns of β-lactams and β-lactamase inhibitors in Klebsiella pneumoniae
DS Sutaria, B Moya, KB Green, TH Kim, X Tao, Y Jiao, A Louie, ...
Antimicrobial agents and chemotherapy 62 (6), e00282-18, 2018
762018
Doxorubicin and paclitaxel co-bound lactosylated albumin nanoparticles having targetability to hepatocellular carcinoma
C Lee, B Kim, S Lee, TH Kim, JO Kim, ES Lee, KT Oh, HG Choi, SD Yoo, ...
Colloids and Surfaces B: Biointerfaces 152, 183-191, 2017
582017
Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system
JB Lee, A Zgair, J Malec, TH Kim, MG Kim, J Ali, C Qin, W Feng, M Chiang, ...
Journal of Controlled Release 286, 10-19, 2018
552018
Determination of acrylamide and glycidamide in various biological matrices by liquid chromatography–tandem mass spectrometry and its application to a pharmacokinetic study
TH Kim, S Shin, KB Kim, WS Seo, JC Shin, JH Choi, KY Weon, SH Joo, ...
Talanta 131, 46-54, 2015
532015
Model-based drug development: Application of modeling and simulation in drug development
TH Kim, S Shin, BS Shin
Journal of Pharmaceutical Investigation 48 (4), 431-441, 2018
412018
Optimization of a meropenem-tobramycin combination dosage regimen against hypermutable and nonhypermutable Pseudomonas aeruginosa via mechanism-based modeling and the hollow …
CB Landersdorfer, VE Rees, R Yadav, KE Rogers, TH Kim, PJ Bergen, ...
Antimicrobial agents and chemotherapy 62 (4), e02055-17, 2018
352018
Zika virus replication is substantially inhibited by novel favipiravir and interferon alpha combination regimens
CP Pires de Mello, X Tao, TH Kim, JB Bulitta, JL Rodriquez, JJ Pomeroy, ...
Antimicrobial agents and chemotherapy 62 (1), e01983-17, 2018
352018
Effects of Phytochemical P-Glycoprotein Modulators on the Pharmacokinetics and Tissue Distribution of Doxorubicin in Mice
TH Kim, S Shin, SD Yoo, BS Shin
Molecules 23 (2), 349, 2018
332018
Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials
Y Jiao, B Moya, MJ Chen, AP Zavascki, H Tsai, X Tao, DS Sutaria, ...
Antimicrobial agents and chemotherapy 63 (7), e00425-19, 2019
312019
Physiologically Relevant In Vitro-In Vivo Correlation (IVIVC) Approach for Sildenafil with Site-Dependent Dissolution
TH Kim, S Shin, SW Jeong, JB Lee, BS Shin
Pharmaceutics 11 (6), 251, 2019
272019
Simultaneous determination of phenoxyethanol and its major metabolite, phenoxyacetic acid, in rat biological matrices by LC–MS/MS with polarity switching: Application to ADME …
TH Kim, MG Kim, MG Kim, BS Shin, KB Kim, JB Lee, SH Paik, SD Yoo
Talanta 144, 29-38, 2015
272015
Pharmacokinetics and metabolite profiling of fimasartan, a novel antihypertensive agent, in rats
TH Kim, S Shin, M Bashir, YH Chi, SH Paik, JH Lee, HJ Choi, JH Choi, ...
Xenobiotica 44 (10), 913-925, 2014
262014
A novel nucleoside rescue metabolic pathway may be responsible for therapeutic effect of orally administered cordycepin
JB Lee, M Radhi, E Cipolla, RD Gandhi, S Sarmad, A Zgair, TH Kim, ...
Scientific reports 9 (1), 1-12, 2019
252019
Clinical regimens of favipiravir inhibit Zika virus replication in the hollow-fiber infection model
CP Pires de Mello, X Tao, TH Kim, M Vicchiarelli, JB Bulitta, A Kaushik, ...
Antimicrobial Agents and Chemotherapy 62 (9), e00967-18, 2018
252018
Development of a Physiologically Relevant Population Pharmacokinetic in Vitroin Vivo Correlation Approach for Designing Extended-Release Oral Dosage …
TH Kim, S Shin, JB Bulitta, YS Youn, SD Yoo, BS Shin
Molecular pharmaceutics 14 (1), 53-65, 2017
252017
Population pharmacokinetic modeling of the enterohepatic recirculation of fimasartan in rats, dogs, and humans
TH Kim, S Shin, CB Landersdorfer, YH Chi, SH Paik, J Myung, R Yadav, ...
The AAPS journal 17 (5), 1210-1223, 2015
252015
A novel in vitro permeability assay using three-dimensional cell culture system
JB Lee, SH Son, MC Park, TH Kim, MG Kim, SD Yoo, S Kim
Journal of biotechnology 205, 93-100, 2015
222015
In vivo absorption and disposition of α-cedrene, a sesquiterpene constituent of cedarwood oil, in female and male rats
TH Kim, SD Yoo, HS Lee, KM Lee, SH Seok, MG Kim, BH Jung, MG Kim, ...
Drug metabolism and pharmacokinetics 30 (2), 168-173, 2015
222015
系统目前无法执行此操作,请稍后再试。
文章 1–20